A Study of RO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4

NCT00869661 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

413

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Copegus
DRUG: Copegus
DRUG: Pegasys
DRUG: Pegasys
DRUG: RO5024048
DRUG: RO5024048
DRUG: RO5024048
DRUG: RO5024048

Sponsor

Hoffmann-La Roche